Moreover, obesity is associated in some studies with an increased risk of rheumatic diseases (60, 61); and recent reports have showed a negative association between high BMI and response to anti-TNF agents in both RA and SpA (62–64), suggesting that fat mass may affect the response to biologic agents. Here, TNF is linked to Obesity.